These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 25212570)
1. Down-regulation of Akt by methanol extracts of Impatiens balsamina L. promotes apoptosis in human oral squamous cell carcinoma cell lines. Shin JA; Ryu MH; Kwon KH; Choi B; Cho SD J Oral Pathol Med; 2015 Jul; 44(6):420-8. PubMed ID: 25212570 [TBL] [Abstract][Full Text] [Related]
2. YM155 Down-Regulates Survivin and Induces P53 Up-Regulated Modulator of Apoptosis (PUMA)-Dependent in Oral Squamous Cell Carcinoma Cells. Yan X; Su H Med Sci Monit; 2017 Apr; 23():1963-1972. PubMed ID: 28435150 [TBL] [Abstract][Full Text] [Related]
3. The antitumor effects of herbal medicine Triphala on oral cancer by inactivating PI3K/Akt signaling pathway: based on the network pharmacology, molecular docking, in vitro and in vivo experimental validation. Hu S; Li S; Xu Y; Huang X; Mai Z; Chen Y; Xiao H; Ning W; Gaus S; Savkovic V; Lethaus B; Zimmerer R; Acharya A; Ziebolz D; Schmalz G; Huang S; Zhao J; Hu X Phytomedicine; 2024 Jun; 128():155488. PubMed ID: 38493718 [TBL] [Abstract][Full Text] [Related]
4. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma. Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314 [TBL] [Abstract][Full Text] [Related]
5. AMPK-activated protein kinase activation by Impatiens balsamina L. is related to apoptosis in HSC-2 human oral cancer cells. Shin JA; Kwon KH; Cho SD Pharmacogn Mag; 2015; 11(41):136-42. PubMed ID: 25709223 [TBL] [Abstract][Full Text] [Related]
6. Kochia scoparia induces apoptosis of oral cancer cells in vitro and in heterotopic tumors. Han HY; Lee HE; Kim HJ; Jeong SH; Kim JH; Kim H; Ryu MH J Ethnopharmacol; 2016 Nov; 192():431-441. PubMed ID: 27616033 [TBL] [Abstract][Full Text] [Related]
7. Arglabin is a plant sesquiterpene lactone that exerts potent anticancer effects on human oral squamous cancer cells via mitochondrial apoptosis and downregulation of the mTOR/PI3K/Akt signaling pathway to inhibit tumor growth in vivo. He W; Lai R; Lin Q; Huang Y; Wang L J BUON; 2018; 23(6):1679-1685. PubMed ID: 30610794 [TBL] [Abstract][Full Text] [Related]
8. Targeting of Survivin Pathways by YM155 Inhibits Cell Death and Invasion in Oral Squamous Cell Carcinoma Cells. Zhang W; Liu Y; Li YF; Yue Y; Yang X; Peng L Cell Physiol Biochem; 2016; 38(6):2426-37. PubMed ID: 27287458 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the PI3K/AKT Pathway Sensitizes Oral Squamous Cell Carcinoma Cells to Anthracycline-Based Chemotherapy In Vitro. Smolensky D; Rathore K; Bourn J; Cekanova M J Cell Biochem; 2017 Sep; 118(9):2615-2624. PubMed ID: 27649518 [TBL] [Abstract][Full Text] [Related]
10. YM155 induces apoptosis through downregulation of specificity protein 1 and myeloid cell leukemia-1 in human oral cancer cell lines. Sachita K; Yu HJ; Yun JW; Lee JS; Cho SD J Oral Pathol Med; 2015 Nov; 44(10):785-91. PubMed ID: 25475012 [TBL] [Abstract][Full Text] [Related]
11. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors. Iwase M; Yoshiba S; Uchid M; Takaoka S; Kurihara Y; Ito D; Hatori M; Shintani S Int J Oncol; 2007 Nov; 31(5):1141-7. PubMed ID: 17912441 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of BI-D1870 on human oral squamous cell carcinoma. Chiu CF; Bai LY; Kapuriya N; Peng SY; Wu CY; Sargeant AM; Chen MY; Weng JR Cancer Chemother Pharmacol; 2014 Feb; 73(2):237-47. PubMed ID: 24241211 [TBL] [Abstract][Full Text] [Related]
13. Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors. Lai JP; Sandhu DS; Yu C; Moser CD; Hu C; Shire AM; Aderca I; Murphy LM; Adjei AA; Sanderson S; Roberts LR Liver Int; 2010 Nov; 30(10):1522-8. PubMed ID: 21040406 [TBL] [Abstract][Full Text] [Related]
14. Genistein nanoformulation promotes selective apoptosis in oral squamous cell carcinoma through repression of 3PK-EZH2 signalling pathway. Dev A; Sardoiwala MN; Kushwaha AC; Karmakar S; Choudhury SR Phytomedicine; 2021 Jan; 80():153386. PubMed ID: 33113500 [TBL] [Abstract][Full Text] [Related]
15. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin. Fetz V; Bier C; Habtemichael N; Schuon R; Schweitzer A; Kunkel M; Engels K; Kovács AF; Schneider S; Mann W; Stauber RH; Knauer SK Int J Cancer; 2009 May; 124(9):2033-41. PubMed ID: 19130609 [TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells. Aggarwal S; John S; Sapra L; Sharma SC; Das SN Cancer Chemother Pharmacol; 2019 Mar; 83(3):451-461. PubMed ID: 30519710 [TBL] [Abstract][Full Text] [Related]
17. Furano-1,2-Naphthoquinone Inhibits Src and PI3K/Akt Signaling Pathways in Ca9-22 Human Oral Squamous Carcinoma Cells. Lin KL; Chien CM; Tseng CH; Chen YL; Chang LS; Lin SR Integr Cancer Ther; 2014 May; 13(3):NP18-28. PubMed ID: 22505597 [TBL] [Abstract][Full Text] [Related]
18. Isoliquiritigenin Inhibits Oral Squamous Cell Carcinoma and Overcomes Chemoresistance by Destruction of Survivin. Zhou Z; Han S; Liao J; Wang R; Yu X; Li M Am J Chin Med; 2023; 51(8):2221-2241. PubMed ID: 37930332 [TBL] [Abstract][Full Text] [Related]
19. Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway. Qu Y; He Y; Ruan H; Qin L; Han Z Cancer Med; 2023 Mar; 12(5):5781-5797. PubMed ID: 36336972 [TBL] [Abstract][Full Text] [Related]
20. Deoxypodophyllotoxin Induces ROS-Mediated Apoptosis by Modulating the PI3K/AKT and p38 MAPK-Dependent Signaling in Oral Squamous Cell Carcinoma. Seo JH; Yoon G; Park S; Shim JH; Chae JI; Jeon YJ J Microbiol Biotechnol; 2022 Sep; 32(9):1103-1109. PubMed ID: 36039387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]